1[1]Greipp PR,San MJ,Durie BG,et al.International staging system for multiple myeloma[J].J Clin Oncol,2005,23(15):3412-3420.
2[2]Modarressi A,Kuriyan M,Harvey G,et al.Heat insoluble cryoglobulin associated with gangrene in multiple myeloma[J].J Clin Apher,2003,18(4):190-193.
3[3]Saunders G.Overview of drug therapy for multiple myeloma[J].J Oncol Pharm Pract,2005,11(3):83-100.
4张之南.血液病诊断及疗效标准.北京:科学出版社,1999.215.
5[6]Sonmez M,Sonmez B,Eren N,et al.Effects of interferon-alpha-2a on Th3 cytokine response in multiple myeloma patients[J].Tumori,2004,90(4):387-389.
6[7]Alexandrakis MG,Passam FH,Sfiridaki A,et al.Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines[J].Int J Biol Markers,2004,19(1):52-57.
7[8]Bergsagel PL,Kuehl WM.Molecular pathogenesis and a consequent classification of multiple myeloma[J].J Clin Oncol,2005,23(26):6333-6338.
8[9]Clark WF,Stewart AK,Rock GA,et al.Plasma exchange when myeloma presents as acute renal failure:a randomized,controlled trial[J].Ann Intern Med,2005,143(11):777-784.
9[10]Arslan O,Arm M,Tek I,et al.Therapeutic plasma exchange in a single center:Ibni Sina experience[J].Transfus Apher Sci,2004,30(3):181-184.
10[11]Goddard IR,Stewart WK,Hodson BA,et al.Plasma exchange as a treatment for endogenous glycosaminoglycan anticoagulant induced haemorrhage in a patient with myeloma kidney[J].Nephron,1990,56(1):94-96.
6Mehta J,Sinqhal S . Hyperviscosity symdrome in plasma cell dyscrasias[J]. Semin Thromb Hemost,2003,29(5):467-471.
7Stephen A Johnson. Adavances in the treatment of Waldenstrom's macroglobulinemia [J ] . Expert Rev Antieancer Ther, 2006, 6(3):329- 334.
8Mcleod BC. Therapeutic apheresis use of human serum albumin,fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange[J]. Best Pract Res Clin Haematol, 2006,19(1):157-167.
